{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:54:14Z","timestamp":1771667654525,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key Research and Development Project of Sichuan Province","award":["no. 2018SZ0068"],"award-info":[{"award-number":["no. 2018SZ0068"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>The glucagon-like peptide-1 receptor agonists (GLP-1 RAs) class agent has grown rapidly in the last decade due to its effects on lowering HbA1c and weight and the low possibility of hypoglycemia. However, GLP-1 RAs are not devoid of adverse effects among which nausea and vomiting rank first, which reduce adherence to treatment. Accumulated evidences proved that acupuncture can properly treat nausea and vomiting caused by various reasons. The study aims at assessing the safety and effectiveness exhibited by acupuncture treatment for patients with nausea and vomiting induced by GLP-1 RAs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and analysis:<\/jats:title>\n            <jats:p>Articles that have been identified via electronically searching databases of MEDLINE, Nature, PubMed, the Cochrane Library, WorldSciNet, EMbase, Science Online, AMED, China National Knowledge Infrastructure, the Wanfang Databse and China Biology Medicine Disc and the Chongqing VIP Chinese Science and Technology Periodical Database from their inception of to December 31, 2019 will be incorporated into the systematic review. The review only adopts Chinese and English. It will also pay attention to searching resources of qualified studies, relevant conference proceedings, potential reference list, as well as related system reviews. Two researchers will take charge of completing the selection of research, the extraction of data as well as the assessment of research quality independently. A random- or fixed-effects model will be employed to synthesize data combining the heterogeneity test. The primary outcomes will be nausea and vomiting, seen from the objective and self-reported assessment. Data analysis will be performed via the RevMan 5 software, and GRADE will help to assess the evidence level. The heterogeneity level will determine whether the random-effects model or the fixed-effects model will be used. The 2 categories will adopt risk ratio (RR) or odds ratio (OR) and 95% confidence interval (CI). Continuous variables will adopt the weighted mean difference or standardized mean difference and 95% CI. Meta-analysis will not be conducted if no assessment, like subgroup analysis, is able to explain existing meaningful heterogeneity. The subgroup analysis shall carefully consider each subgroup in certain case.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>The systematic review does not involve the evaluation of patients\u2019 individual information or patients\u2019 right; thus, there is no need to gain the approval from ethical institution. The article will be published in journals reviewed by peers and present at related conference.<\/jats:p>\n            <jats:p>Registration: Open Science Framework (OSF) Preregistration. 2020, April 8. osf.io\/3fgu8<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000020343","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T03:19:40Z","timestamp":1590635980000},"page":"e20343","source":"Crossref","is-referenced-by-count":2,"title":["Acupuncture for patients with glucagon-like peptide-1 receptor agonists-induced nausea and vomiting"],"prefix":"10.1097","volume":"99","author":[{"given":"Ning","family":"Ding","sequence":"first","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine"},{"name":"Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linzhi","family":"Li","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine"},{"name":"Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Huang","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4417-3312","authenticated-orcid":false,"given":"Rensong","family":"Yue","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"R1-20240521","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"R2-20240521","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrendo.2012.140","article-title":"GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus","volume":"8","author":"Meier","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"R3-20240521","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.2337\/dc12-2454","article-title":"Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine","volume":"36","author":"Riddle","year":"2013","journal-title":"Diabetes Care"},{"key":"R4-20240521","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2337\/dc14-0876","article-title":"Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes","volume":"37","author":"Diamant","year":"2014","journal-title":"Diabetes Care"},{"key":"R5-20240521","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/dom.12596","article-title":"Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists","volume":"18","author":"Madsbad","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"R6-20240521","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1463-1326.2012.01618.x","article-title":"Investigators obotEG-LAS. Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)","volume":"14","author":"Seino","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"R7-20240521","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2337\/diacare.28.5.1092","article-title":"Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes","volume":"28","author":"DeFronzo","year":"2005","journal-title":"Diabetes Care"},{"key":"R8-20240521","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/diacare.28.5.1083","article-title":"Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea","volume":"28","author":"Kendall","year":"2005","journal-title":"Diabetes Care"},{"key":"R9-20240521","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diacare.27.11.2628","article-title":"Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes","volume":"27","author":"Buse","year":"2004","journal-title":"Diabetes Care"},{"key":"R10-20240521","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(10)60590-9","article-title":"Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial","volume":"376","author":"Bergenstal","year":"2010","journal-title":"Lancet"},{"key":"R11-20240521","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/ajg.2017.264","article-title":"Gastric motor dysfunction in patients with functional gastroduodenal symptoms","volume":"112","author":"Park","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R12-20240521","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1365-2702.2012.04114.x","article-title":"Acupuncture prior to surgery to minimise postoperative nausea and vomiting: a systematic review","volume":"21","author":"Holmer Pettersson","year":"2012","journal-title":"J Clin Nurs"},{"key":"R13-20240521","first-page":"1518","article-title":"NIH Consensus Conference","volume":"280","author":"Listed","year":"1998","journal-title":"Acupuncture"},{"key":"R14-20240521","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2044.1997.143-az0147.x","article-title":"Acupuncture in the prevention of postoperative nausea and vomiting","volume":"52","author":"Al-Sadi","year":"2020","journal-title":"Anaesthesia"},{"key":"R15-20240521","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R17-20240521","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2020","journal-title":"Stat Med"},{"key":"R19-20240521","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R20-20240521","first-page":"0","article-title":"Acupuncture for nausea and vomiting: an update of clinical and experimental studies","volume":"129","author":"Streitberger","year":"2020","journal-title":"Auton Neurosci"},{"key":"R21-20240521","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1213\/01.ANE.0000068580.00245.95","article-title":"Consensus guidelines for managing postoperative nausea and vomiting","volume":"97","author":"Gan","year":"2003","journal-title":"Anesth Analg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T20:03:30Z","timestamp":1716321810000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020343"}},"subtitle":["A systematic review protocol"],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":19,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000020343","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]}}}